Asparaginase is an enzyme that catalzes the hydrolysis of l-asparagine to l-aspartic acid and ammonia. It is also known as crisantaspase. Asparaginase products are isolated from different forms of bacteria, namely Escherichia coli and Erwinia chrysanthemi. They inhibit protein synthesis in tumor cells by depriving them of an amino acid asparagine. They are widely used in food manufacturing industry and healthcare industry as a medication. They are also used to treat acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and non-Hodgkin’s lymphoma. They are given by injection into a vein, muscle, or under the skin. Asparaginase enzyme is used in the food manufacturing to reduce the formation of acrylamide, which is a carcinogen in the starch containing food products for instance biscuits and snacks.
According to study, “Global Asparaginase Market to reach USD XXX million by 2026” the key companies operating in the global asparaginase market are Jazz Pharmaceuticals Plc, Kyowa Hakko Kirin Co., Ltd., Shire Plc, Mingxing Pharma, Medac GmbH, United Biotech Pvt. Ltd., Qianhong Bio-pharma, Taj Pharmaceuticals, Exova SL Pharma Inc, Novus Biologicals. Key companies have a considerable opportunity in global asparaginase market through collaboration with end-users i.e. food and pharmaceutical manufacturers.
Based on type, asparaginase market is segmented as Erwinia Chrysanthemi, Escherichia Coli and Pegylated. In addition, based on application, market is segmented as food industry, healthcare and others. Among these, the healthcare Industry segment is predictable to contribute to the significant revenue share with a relatively high growth rate over the forecast period in the global market followed by food industry segment with a relatively high growth rate considering both value & volume in the global Asparaginase market.
The asparaginase market is driven by increase in number of patients with acute lymphocytic leukemia, followed by high growth rate of the healthcare sector, rise in number of cancer patients in the United States and increase in investments of the market players for the research & development (R&D) or production of Asparaginase according to the regulatory specification. However, increase in cost of the asparaginase drugs and side effects of Asparaginase on human body such as pancreatitis, mild bone marrow suppression, and anticoagulant factor resulting in stroke and bleeding may impact the market. Moreover, increase in number of blood tumors patients across the globe is a key opportunity for market. Furthermore, rise in demand for human brain function & in ammonia physiology and high adoption to treat childhood cancer treatments are major trend for market.
Based on geography, the North-American is the leading region in global asparaginase market owing to significant revenue share of the region in the pharmaceutical industry and rise in cases of Leukemia in the region. Whereas, the Asian-Pacific and European regions are anticipated to exhibit highest growth rate due to increase in population along with rise in disposable income coupled with growth in food manufacturing industry over the forecast period. In near future, it is predicted that the global asparaginase market will be reached at rapid pace as a result of high growth rate of pharmaceutical and food industry during the forecast period.
For More Information, click on the link below:-
Global Asparaginase Market Research Report
Related Reports:-
Global Asparaginase Market Research (2015-2019) and Future Forecast (2020-2025)
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
